Vitiligo: Pathogenesis, clinical variants and treatment approaches

Giannicola Iannella, Antonio Greco, Dario Didona, Biagio Didona, Guido Granata, Alessandra Manno, Benedetta Pasquariello, Giuseppe Magliulo

Research output: Contribution to journalArticle

Abstract

Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown, which usually occurs with asymptomatic whitish patch or macule. Although several hypotheses have been proposed in the literature, the leading theory is still the auto-immune etiology linked to specific genetic mutations. Vitiligo can also be associated with several autoimmune diseases, including autoimmune thyroid diseases, alopecia areata, and halo nevi. Sensorineural hearing loss was reported in several vitiligo patients due to a reduction in the number of melanocytes contained in the membranous labyrinth of the inner ear. Because of its complexity, several therapeutic options are available to treat this systemic disease.

Original languageEnglish
Pages (from-to)335-343
Number of pages9
JournalAutoimmunity Reviews
Volume15
Issue number4
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Vitiligo
Inner Ear
Autoimmune Diseases
Halo Nevi
Alopecia Areata
Sensorineural Hearing Loss
Melanocytes
Thyroid Diseases
Pigmentation
Chronic Disease
Therapeutics
Mutation

Keywords

  • Autoimmune diseases
  • Hearing loss
  • NB-UVB
  • Oxidative stress
  • Prednisolone
  • Vitiligo

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Iannella, G., Greco, A., Didona, D., Didona, B., Granata, G., Manno, A., ... Magliulo, G. (2016). Vitiligo: Pathogenesis, clinical variants and treatment approaches. Autoimmunity Reviews, 15(4), 335-343. https://doi.org/10.1016/j.autrev.2015.12.006

Vitiligo : Pathogenesis, clinical variants and treatment approaches. / Iannella, Giannicola; Greco, Antonio; Didona, Dario; Didona, Biagio; Granata, Guido; Manno, Alessandra; Pasquariello, Benedetta; Magliulo, Giuseppe.

In: Autoimmunity Reviews, Vol. 15, No. 4, 01.04.2016, p. 335-343.

Research output: Contribution to journalArticle

Iannella, G, Greco, A, Didona, D, Didona, B, Granata, G, Manno, A, Pasquariello, B & Magliulo, G 2016, 'Vitiligo: Pathogenesis, clinical variants and treatment approaches', Autoimmunity Reviews, vol. 15, no. 4, pp. 335-343. https://doi.org/10.1016/j.autrev.2015.12.006
Iannella, Giannicola ; Greco, Antonio ; Didona, Dario ; Didona, Biagio ; Granata, Guido ; Manno, Alessandra ; Pasquariello, Benedetta ; Magliulo, Giuseppe. / Vitiligo : Pathogenesis, clinical variants and treatment approaches. In: Autoimmunity Reviews. 2016 ; Vol. 15, No. 4. pp. 335-343.
@article{90af659535334a92b1e45fad5039d158,
title = "Vitiligo: Pathogenesis, clinical variants and treatment approaches",
abstract = "Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown, which usually occurs with asymptomatic whitish patch or macule. Although several hypotheses have been proposed in the literature, the leading theory is still the auto-immune etiology linked to specific genetic mutations. Vitiligo can also be associated with several autoimmune diseases, including autoimmune thyroid diseases, alopecia areata, and halo nevi. Sensorineural hearing loss was reported in several vitiligo patients due to a reduction in the number of melanocytes contained in the membranous labyrinth of the inner ear. Because of its complexity, several therapeutic options are available to treat this systemic disease.",
keywords = "Autoimmune diseases, Hearing loss, NB-UVB, Oxidative stress, Prednisolone, Vitiligo",
author = "Giannicola Iannella and Antonio Greco and Dario Didona and Biagio Didona and Guido Granata and Alessandra Manno and Benedetta Pasquariello and Giuseppe Magliulo",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.autrev.2015.12.006",
language = "English",
volume = "15",
pages = "335--343",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Vitiligo

T2 - Pathogenesis, clinical variants and treatment approaches

AU - Iannella, Giannicola

AU - Greco, Antonio

AU - Didona, Dario

AU - Didona, Biagio

AU - Granata, Guido

AU - Manno, Alessandra

AU - Pasquariello, Benedetta

AU - Magliulo, Giuseppe

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown, which usually occurs with asymptomatic whitish patch or macule. Although several hypotheses have been proposed in the literature, the leading theory is still the auto-immune etiology linked to specific genetic mutations. Vitiligo can also be associated with several autoimmune diseases, including autoimmune thyroid diseases, alopecia areata, and halo nevi. Sensorineural hearing loss was reported in several vitiligo patients due to a reduction in the number of melanocytes contained in the membranous labyrinth of the inner ear. Because of its complexity, several therapeutic options are available to treat this systemic disease.

AB - Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown, which usually occurs with asymptomatic whitish patch or macule. Although several hypotheses have been proposed in the literature, the leading theory is still the auto-immune etiology linked to specific genetic mutations. Vitiligo can also be associated with several autoimmune diseases, including autoimmune thyroid diseases, alopecia areata, and halo nevi. Sensorineural hearing loss was reported in several vitiligo patients due to a reduction in the number of melanocytes contained in the membranous labyrinth of the inner ear. Because of its complexity, several therapeutic options are available to treat this systemic disease.

KW - Autoimmune diseases

KW - Hearing loss

KW - NB-UVB

KW - Oxidative stress

KW - Prednisolone

KW - Vitiligo

UR - http://www.scopus.com/inward/record.url?scp=84959116505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959116505&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2015.12.006

DO - 10.1016/j.autrev.2015.12.006

M3 - Article

C2 - 26724277

AN - SCOPUS:84959116505

VL - 15

SP - 335

EP - 343

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 4

ER -